Abstract: LPS induces dendritic cell (DC) activation, but the precise in vivo mechanism is unclear since DCs express low levels of TLR4. Here, it is shown that DCs can be activated in response to LPS through a bystander mechanism. This result was obtained using chimeric mice reconstituted with LPSresponsive and nonresponsive bone marrow cells. 
INTRODUCTION
Specialized families of pattern recognition receptors (PRRs), expressed predominantly by hematopoetic cells, bind highly conserved pathogen associated molecular patterns (PAMPs) and activate the innate immune system. The outcome of a microbial infection depends on the efficiency of the innate immune response to combat microbes and induce adaptive immune responses against the invading pathogen. DCs are believed to be critical cellular mediators of this process that serve to link the innate and adaptive immune systems, resulting in robust and long-lasting immunity [1] .
LPS, the most studied and well-characterized PAMP, mediates much of its pleiotropic effects on APCs. In vivo coadministration of LPS, along with soluble proteins, results in lasting antigen-specific T cell memory [2] . LPS enhances antigen presentation and costimulatory molecule expression by DCs and induces the synthesis and release of proinflammatory mediators [3] . The molecular mechanisms by which LPS activates DCs are well studied. A great deal is known concerning how LPS binds and stimulates through the TLR4 pathway, but precisely which cells are directly or indirectly stimulated by LPS in vivo is still being actively pursued [4] . For example, LPS may mediate its effects by directly binding TLR4 expressed on DCs. However, human and mouse DCs express low levels of TLR4 mRNA and surface molecules [5] [6] [7] [8] . Notwithstanding the very low levels of surface TLR4, it has been demonstrated that after LPS exposure, DCs attain an activated phenotype and hence prime T cells in vivo with enhanced efficiency [9] . Currently, there is no in vivo experimental evidence that explains the profound maturation of DCs, in spite of low TLR4 expression, following LPS exposure. Injection of LPS in the mouse footpad results in accumulation of LPS in the subcapsular and medullary sinuses of draining lymph nodes [10] . Compared with DCs, macrophages are the predominant immune cells in the subcapsular sinus. Interestingly, macrophages express very high levels of TLR4 compared with DCs [7] . These anatomical and physiological constraints could limit the accessibility of DCs to LPS. It is logical that LPS would, therefore, be encountered by macrophages, endothelial and epithelial cells, which upon activation may initiate a cascade of events resulting in the release of inflammatory mediators and tissue factors. Consistent with this idea are reports suggesting that DC maturation can be induced after release of inflammatory mediators [11, 12] . Specifically, IFN-␥ and IFN-␣ have been demonstrated to be potent stimuli of DC maturation [13] and the adjuvanticity of CFA, which contains several TLR ligands, has been shown to be dependent on IFN receptors [14] .
Thus, considering these important data, we tested whether LPS was capable of indirectly activating DCs using an in vivo system and began to investigate the critical molecules involved in this process. A mixed bone-marrow chimera mouse model was developed, and results showed that LPS activated LPS nonresponsive DCs, but only in the presence of LPS-responsive cells. In vivo LPS conditioning of the LPS-responsive and bystander population endowed them both with the ability to produce IFN-␥ in response to TLR9 stimulation in vitro. Our data indicate that natural killer DCs (NKDCs) were a source of IFN-␥ after LPS stimulation, suggesting that they may play a role in conditioning cells of the innate immune system in a bystander fashion. 
MATERIALS AND METHODS

Reagents
Generation of chimeric mice
C3H/HeJ recipient mice were ␥-irradiated twice ϳ3 h apart with 550 rads and reconstituted with ϳ2 ϫ 10 6 bone-marrow cells of each relevant donor strain. Bone-marrow cells were depleted of T cells in most of the mixed bone-marrow chimeras made, but it was noteworthy that there was a no significant difference in the mortality of mice in depleted as compared with the nondepleted chimeras (data not shown). Eight weeks after reconstitution, chimerism was ascertained by analysis of blood leukocytes by surface staining and flow cytometric analysis of the respective MHC class I/II molecules. When necessary chimeric mice were matched between groups, such that a comparable level of chimerism was present in the mice.
Cell fractionation and flow cytometry
Density gradient fractionation of DCs was followed as previously published [15] . Briefly, spleens were treated with 1 ml of 3.3 mg/ml of collagenase D (Roche Diagnostics Corporation, Indianapolis, IN) in MEM, 2% fetal bovine serum (FBS, GIBCO BRL, Grand Island, NY), 10 mM HEPES (GIBCO). Splenic tissue was incubated for 30 min at 37°C, 5% CO 2 . After treatment with 0.1 ml of 0.1 M EDTA for 5 min at room temperature, spleen tissue was passed through cell strainers and rinsed with Ca ϩϩ /Mg ϩϩ -free BSS. Red blood cells were lysed, and cells were resuspended in 3 ml of 35% BSA in PBS (4:1, vol/vol), added to ultra-clear centrifuge tubes (Beckman, Palo Alto, CA), with an additional 3 ml Ca ϩϩ /Mg ϩϩ free BSS layered on top. After centrifugation at 9500 g for 25 min at 4°C, cells from the interface were collected and washed with BSS. Cells were resuspended in either Complete Tumor Media (CTM: MEM with FBS, amino acids, salts, and antibiotics) or staining buffer (BSS, 3% FCS, 0.1% NaN 3 ) and counted on a Z1 particle counter (Beckman Coulter, Miami, FL). Surface staining of cells for flow cytometry was done as described before [16, 17] . Briefly, cells were resuspended in staining buffer, nonspecific binding was blocked using a combination of 2.4G2 hybridoma supernatant, 5% heat inactivated normal mouse serum and 10 g/ml human IgG (SigmaAldrich, St. Louis, MO). Cells were incubated on ice with antibodies for 30 min and then washed and resuspended in staining buffer before analysis on a FACSCalibur flow cytometer. Data were analyzed using Flow jo software (Tree Star Inc., Ashland, OR).
Cell purification and culturing
Cells were fractionated from whole spleens of PBS and upLPS-treated chimeric mice using CD11c MACS beads and columns (Miltenyi Biotech, Auburn, CA). We consistently obtained 90 -95% pure CD11c ϩ cells after MACS bead purification. We further separated these cells using anti-IA b (C57BL/6) PE followed by anti-PE (Miltenyi Biotech, Auburn, CA) on MACS columns. 
Intracellular IFN-␥ cytokine staining
Low-density cells were fractionated from whole spleens of PBS and upLPStreated C57BL/6 mice by density-gradient centrifugation for initial experiments and cultured with or without CpG for 5 h. For later experiments, CD11c ϩ cells were enriched from density gradient fractionated spleen cells using CD11c MACS beads and columns (Miltenyi Biotech, Auburn, CA). CD11c ϩ cells were then cultured, for a total of 5 h, in a 96-well flat-bottom plate and stimulated with CTM alone or 1 g of CpG. Brefeldin A was added to all cultures at a concentration of 10 g/ml. Cultured cells were washed and surface stained on ice with anti-CD49b (pan-NK cell marker) conjugated to APC; IA b , or IE k conjugated to FITC. We added 1 g/ml of brefeldin A to the FACS staining buffer, which was used for washing the cells, to prevent leaching of IFN-␥ during the intracellular staining. Surface-stained cells were fixed with 2% paraformaldehyde and later washed with ice-cold FACS staining buffer containing 2.5% saponin followed by the addition of anti-IFN-␥ conjugated to PE and incubated on ice for 30 min. Cells were washed three times with FACS staining buffer containing 2.5% saponin and once with ice-cold PBS and analyzed by flow cytometry. Isotype controls were also run to establish appropriate gate settings.
Real-time PCR
T-bet gene expression was analyzed by quantitative real-time PCR. Total cellular RNA was extracted from splenic C3H/HeJ (CD11c ϩ and IE k ) cells using RNeasy mini-kit (Qiagen Sciences, Germantown, MD). RNA was reverse transcribed using SuperScript II RNase H (Invitrogen Life Technologies, Carlsbad, CA). Real-time PCR assays used a final volume of 40 l containing 20 l iQ SYBR Green Supermix (Bio-Rad Laboratories), 4 l gene-specific primers (640 nmol), 5 l cDNA, and 11 l H 2 O. The starting concentration of cDNA was 30 ng, and eightfold dilutions were also completed to ensure quality control of the real-time assay. Primers specific for the amplification of murine HPRT and T-bet were synthesized by Invitrogen Life Technologies (Carlsbad, CA). HPRT: sense strand 5Ј-CTCCTCAGACCGCTTTTTGC-3Ј and anti-sense 6 ) were added to the wells of a 96-well flat-bottom plate along with 100 ng of PAMPs. The chimera numbers correspond to the numbers in Table 2. strand 5Ј-TAACCTGGTTCATCATCGCTAATC-3Ј. T-bet: sense strand 5Ј-CGGGAGAACTTTGAGTCCATGT-3Ј and anti-sense strand 5Ј-GCTGGCCT-GGAAGGTCG-3Ј [18, 19] . The cycling protocol was as follows: 95°C 3 min, followed by 45 cycles of 95°C denaturation for 15 s and gene-specific annealing and extension at 59°C for 70 s. A melt-curve was generated at the end of each real-time assay to check for nonspecific amplification of cDNA. Amplification of HPRT acted as a control. The fold difference in cDNA levels were quantified using the ddCT method [20] . Real-time PCR was performed using the Bio-Rad iCycler.
RESULTS
Effect of LPS on DCs in vivo
In vivo administration of LPS activates cells through the wellcharacterized TLR4 pathway. We used an in vivo system to test whether activation of DCs by LPS was direct or indirect. We compared ultrapure LPS (upLPS) obtained from Alexis Pharmaceuticals to LPS (Sigma Aldrich) and assayed for DC activation. An array of molecules (CD40, CD80, CD86, MHC class II and 41BB ligand) considered as phenotypic activation markers for DCs were monitored by flow cytometry. Results revealed that CD86 was an ideal, consistent, and representative biomarker to assess the phenotypic activation status of DCs. As measured by flow cytomtery, CD86 was increased on DCs from LPS-responsive (C57BL/6) mice after stimulation with both types of LPS ranging from a dose of 0.01 to 100 g (Fig. 1A) . It was unexpected and important to note that after administration of higher concentrations (1-100 g) of LPS, DCs in C3H/HeJ mice demonstrated a marked up-regulation of CD86 (Fig. 1, A, right panel and B, left panel) . Nevertheless, the DCs in C3H/HeJ mice as identified by MHC class II (IE k ) and CD11c ϩ did not respond to upLPS at any given concentration, which is consistent with previous reports [21] . Time kinetic evaluation of DC phenotypic activation revealed that up-regulation of activation markers peaked at 5 h post-LPS administration, and by 24 h, a significant number of DCs expressed less CD86, as shown in Fig. 2, A and B.
Bystander activation of DCs in response to LPS occurs in vivo
To test whether LPS induced direct and indirect activation of DCs, we generated mixed bone-marrow chimeras, in which irradiated C3H/HeJ mice (recipients) were reconstituted with C57BL/6 and C3H/HeJ bone-marrow cells in differing proportions (Fig. 3A) . After ϳ8 wk of bone-marrow reconstitution, upLPS was administered, and 5 h later, splenic DCs were analyzed for their activation status and compared with a PBS control from the chimeric mice (60:40). DCs originating from C57BL/6 and C3H/HeJ bone-marrow cells up-regulated CD86 in response to in vivo injection of upLPS (Fig. 3B) . We postulated that this in vivo activation of C3H/HeJ DCs occurred as a consequence of a bystander effect, as C3H/HeJ DCs were not activated in response to upLPS unless bone marrow cells from C57BL/6 background were present (Fig. 3B) . Further documentation of this bystander activation was re-enforced as the quantitative increase of CD86 on C3H/HeJ DCs was directly proportional to the level of chimerism with C57BL/6 bone marrow cells (Fig. 3C) . Specifically, the expression of CD86 by C3H/HeJ DCs declined as the proportion of C57BL/6 cells decreased (Fig. 3C) . It is noteworthy, however, that the DCs in the chimeric mouse with ϳ99% reconstitution from C3H/HeJ bone marrow cells were activated by less pure LPS (data not shown). Thus, bystander activation of LPS nonresponsive DCs can occur in vivo in response to LPS-induced inflammatory mediators.
A hallmark of LPS-induced responses is the release of inflammatory mediators by a variety of cell types [22] . It is, therefore, plausible that LPS-mediated bystander activation of DCs could occur as a consequence of release of soluble inflammatory mediators and/or via cell-to-cell adhesion and/or interaction. Recent in vitro experiments using LPS suggest that cell adhesion/interaction is unlikely to make a major contribution to bystander activation [12] , but other studies have shown evidence for both cell-to-cell contact and soluble mediators [4, 13] . Thus, we decided to focus on the contribution of soluble mediators in bystander activation of DCs such as those dependent on MyD88 [23, 24] .
We used the same strategy to generate chimeric mice wherein the C3H/HeJ recipient mice were reconstituted with bone marrow cells either from C57BL/6 or MyD88 Ϫ/Ϫ mice along with C3H/HeJ bone marrow cells. Reconstituted mice were i.p. injected with upLPS, and 5 h later, DCs analyzed by flow cytometry. Results from the wild-type chimeric mice revealed optimal up-regulation of CD86 on C57BL/6 and C3H/ HeJ DCs, although CD86 up-regulation on the C3H/HeJ DCs was less than on the C57BL/6 DCs (Fig. 4A) . The same trend was also observed in the chimeric mice reconstituted with 
MyD88
Ϫ/Ϫ bone marrow cells arguing for the minimal role of MyD88 in inducing CD86 through bystander activation (Fig.  4B) . Another study demonstrated even more up-regulation of CD86 on MyD88 Ϫ/Ϫ DCs in response to LPS [25] . Ultimately, we found that CD86 up-regulation by the bystander cells was largely proportional to the LPS-responsive cells regardless of whether the responsive cells expressed MyD88.
Contribution of IFN-␥ as a mediator of bystander activation
IFN-␥ is expressed in variable quantities secondary to intracellular infections by MyD88
Ϫ/Ϫ macrophages [26] . Release of IFN-␣ and ␤ can also occur in a MyD88-independent manner in response to LPS. IFN-␣ is known to activate STAT1, which is critical for the expression of IFN-␥ [26] . These results, and other data showing effects on T cells [4] , suggest that IFN-␥ can be released in response to LPS, and hence, we decided to evaluate the role of IFN-␥ in bystander DC activation.
IFN-␥ is a signature cytokine of Th1 responses [27] , but it has been shown that cells of the innate immune system produce IFN-␥ in response to LPS [28] and that IFN-␥ enhances the antigen-presenting capabilities of DCs and macrophages and promotes the killing of intracellular pathogens in macrophages [29] . The role of IFN-␥ in mediating bystander activation of DCs in response to LPS in vivo is unknown; hence, we evaluated the role of IFN-␥ and IFN-␥R in this process. We made chimeric mice such that C3H/HeJ recipient mice were reconstituted with bone marrow cells from either C57BL/6, IFN-␥ Ϫ/Ϫ , and IFN-␥R Ϫ/Ϫ , mice along with bone marrow from C3H/HeJ mice. In response to upLPS administration, C3H/HeJ DCs up-regulated CD86 in chimeric mice reconstituted with bone marrow from C57BL/6, IFN-␥ Ϫ/Ϫ , or IFN-␥R Ϫ/Ϫ mice (Fig. 5) .
Thus, IFN-␥ and the IFN-␥R were dispensable in LPS mediated bystander phenotypic activation. However, it is unclear from these data whether bystander-activated cells would have similar functional capabilities compared with their wildtype counterparts.
Bystander conditioning favors enhanced responsiveness to PAMPs
To assess the functional capacity of bystander-activated innate cells, we examined the response of direct and bystander- activated cells to various PAMPs. Chimeric mice were injected with upLPS, 5 h later C57BL/6 and C3H/HeJ CD11c ϩ cells were enriched using anti-IA b or -IE k (respectively) by magnetic bead separation, as described in the Materials and Methods. Cell yields from these bone-marrow chimeric mice were proportional to the level of chimerism (Table 1) . These primary cultures are representative of innate immune cells since multiple cell populations can up-regulate CD11c or even MHC class II. Nevertheless, the fractionated cells were cultured in vitro in the presence of various PAMPs ( Table 2) . Measurement of IFN-␥ in the supernatants revealed that LPS conditioned the fractionated cells to respond much better to CpG than to other PAMPs. The bulk amount of IFN-␥ detected in the supernatant from the bystander population (C3H/HeJ) was lower than compared with their C57BL/6 counterparts, but the fold increase over no PAMP (compare None to CpG, Table 2 ) was profoundly enhanced in both groups of cells. For example, chimeric mouse number 3 showed Ͻ2 picograms of IFN-␥ with no PAMP, but after CpG treatment, 165 pg were detected, and similar data were obtained for C57BL/6 cells ( Table 2 ). In contrast to upLPS conditioning, C3H/HeJ cells from PBS control mice did not make detectable amounts of IFN-␥ in response to PAMPs (data not shown). These observations suggest LPS-induced inflammatory mediators can activate CD11c ϩ cells in a direct and indirect manner, resulting in enhanced responsiveness to CpG and poly I:C. a Indicates average picogram quantity of IFN-␥ detected in duplicate supernatants as measured by ELISA. Mixed bone marrow chimeric mice were injected with ultra-pure LPS (upLPS) or PBS. After 5 h, spleens were collagenase digested and fractionated using CD11c columns. C57BL/6 and C3H/HeJ CD11c ϩ cells were further separated from each other using anti-IA b and anti-IE k PE antibodies and then by using anti-PE MACS beads as described in the Materials and Methods. C57BL/6 and C3H/HeJ cells were stimulated in the presence or absence of PAMPs and IFN-␥ assayed in the supernatants. Cells from PBS-injected mice were also stimulated with PAMPs in this assay but produced nondetectable levels of IFN-␥ (data not shown). These values are the data derived from 3 separate experiments.
Role of IFN-␥ in mediating functional responsiveness to bystander-activated innate cells
We showed that IFN-␥ Ϫ/Ϫ cells can respond to LPS and lead to activation of C3H/HeJ DCs as measured by CD86 upregulation (Fig. 5) . To ascertain the functional status of the C3H/HeJ cells in the absence of IFN-␥, we injected chimeric mice with upLPS and compared the functional responsiveness of C3H/HeJ (CD11c ϩ IE kϩ ) cells to CpG and poly I:C from IFN-␥ ϩ/ϩ vs. IFN-␥ Ϫ/Ϫ chimeric mice. C3H/HeJ cells from IFN-␥ ϩ/ϩ chimeric mice produced large quantities of IFN-␥ when stimulated with CpG, thus reproducing the previous observation shown in Table 2 , and consistent with the data in Fig. 6 . It was interesting to note that C3H/HeJ cells from IFN-␥ Ϫ/Ϫ chimeric mice, which had up-regulated CD86 in response to upLPS (Fig. 5) , did not produce any detectable levels of IFN-␥ when stimulated with CpG and poly I:C in vitro (Table 3) . Thus, these in vitro data suggest that to attain a functionally competent state to produce IFN-␥, CD11c ϩ IE kϩ cells required IFN-␥ and LPS-induced inflammatory mediators void of IFN-␥ couldn't substitute for IFN-␥. Because primary cell cultures are likely to contain contaminating cells regardless of attempts to purify them, we used intracellular cytokine staining procedure. To identify IFN-␥ producers, LPS was injected into C57BL/6 mice, and 5 h later, BSA density gradient-fractionated cells were cultured in the absence or presence of CpG along with brefeldin A. Surface staining followed by intracellular IFN-␥ staining showed that cells producing IFN-␥ expressed CD11c and CD49b (data not shown). Stringent analysis of these cells revealed that the majority of these low-side scatter cells were also MHC class II ϩ when compared with an isotype-matched control antibody. These data suggested that a major proportion of the IFN-␥-producing population were NKDCs [30 -32] . Therefore, LPS or PBS was injected into C57BL/6 mice, and 5 h later, spleen cells were fractionated using a density gradient and further purified by CD11c magnetic bead separation. CD11c ϩ purified cells were cultured in vitro with CpG in the presence of brefeldin A. Five hours later, the cultured cells were stained for CD49b (DX5), MHC class II, and IFN-␥, and the data show several important points (Fig. 6A) . First, much of the IFN-␥ production was derived from MHC class II ϩ cells making this unlikely to be an activated NK population. Second, consistent with previous reports [4, 30] , we observed that NKDCs from PBS-administered mice did not produce IFN-␥ when stimulated with CpG in vitro, and this result contrasts our observation that in vivo LPS conditioning was not required for detection of intracellular TNF-␣ in response to in vitro CpG stimulation (unpublished observation). Third, and perhaps most importantly, in vivo conditioning with LPS induced these cells to produce IFN-␥, even without PAMP stimulation, which was consistent with IFN-␥ detection in the None (no PAMP) column of Table 2 .
Analysis of the IFN-␥-producing cells, when LPS was administered in mixed bone marrow chimeric mice as that in Table 2 , revealed that CD11c ϩ CD49b ϩ IA bϩ (C57BL/6), or IE kϩ (C3H/HeJ) cells produced IFN-␥ (Fig. 6B) , and in all experiments, the percentage of IFN-␥-producing cells increased when cultured with CpG as opposed to brefeldin A alone. These finding were consistently reproducible in all four experiments that were performed with chimeric mice, and the data are consistent with those shown in Table 2 . Also, unconditioned cells, those receiving PBS in vivo, were unable to produce IFN-␥ even after CpG stimulation (data not shown). Although, it is possible that other cell types, such as activated NK cells were producing IFN-␥, our data clearly suggest that LPS bystander-activated NKDCs (IE kϩ ) produce IFN-␥ in appreciable amounts.
LPS induces T-bet up-regulation in an IFN-␥-dependent manner
T-bet, a member of the T-box transcription factor family, controls Th1 responses [33] . T-bet is expressed in DCs and is necessary for IFN-␥ production, and at the same time, IFN-␥ is known to up-regulate T-bet gene expression, thus having autocrine control [34] . In a time kinetic study, LPS exposure of myeloid cells revealed that IFN-␥ production occurs prior to increase in T-bet mRNA [35] . We decided to investigate the role of IFN-␥ on T-bet gene expression when the cells are activated in a bystander manner. We injected upLPS in IFN-␥ ϩ/ϩ :C3H/HeJ and IFN-␥ Ϫ/Ϫ :C3H/HeJ mice, and 5 h later T-bet mRNA expression in C3H/HeJ (CD11c ϩ IE kϩ ) cells was assessed by real-time PCR. We detected a twofold up-regulation in T-bet mRNA expression within 5 h in the C3H/HeJ (CD11c ϩ IE kϩ ) cells obtained from IFN-␥ chimeric mice (Fig. 7, top) . On the other hand, we observed a profound decrease in T-bet mRNA expression as compared with HPRT mRNA (Fig. 7, bottom 
DISCUSSION
During an ongoing microbial infection, cells of the immune system become activated directly or indirectly after they encounter multiple PAMPs. We have investigated some of these interactions in vivo, and our data suggest that DCs can become activated in a bystander manner through bacterial LPS. An earlier study demonstrated that in response to CpG, TLR9-responsive cells could induce bystander activation of TLR9-deficient DCs, and these bystander-activated DCs had suboptimal T cell priming capabilities [12] . In this report, we set out to uncover mechanism(s) of bystander activation. Our in vivo results demonstrated that LPS can activate DCs in a bystander manner, and second, although IFN-␥ was dispensable for CD86 up-regulation, it played an important role in the induction of T-bet gene and in conditioning innate cells to synthesize IFN-␥.
MyD88 is a key adaptor that is involved in TLR4-and TLR9-mediated signaling [23, 24, 36, 37] . The in vivo role of MyD88 in bystander activation in response to LPS has not been dissected, and in this report, we showed that MyD88-deficient cells were able to induce up-regulation of CD86 expression on LPS-nonresponsive (C3H/HeJ) cells (Fig. 4) . It is also important to note that the MyD88-deficient cells did not appear to up-regulate CD86 to the same extent as the wild-type cells, and this was translated in the bystander response as well. Ultimately, we found that CD86 up-regulation by the bystander cells was proportional to the LPS-responsive cells regardless of whether the responsive cells expressed MyD88. However, this may be an effect on CD86 but perhaps not for other molecules or for the function of the bystander cells.
IFN-␥ plays a pivotal role in determining the effectiveness of the immune response to pathogens. It has been shown that macrophages produce IFN-␥ in response to LPS [28] , and recently, NKDCs have also been identified as a source of IFN-␥ producers [30 -32, 38] . IFN-␥ is also known to activate DCs and enhance antigen-presenting capabilities. We showed that IFN-␥ plays a critical role in enhancing responsiveness of bystander-activated cells to PAMPs, and at least one source of IFN-␥ producers were NKDCs (Fig. 6) . Certainly, other cells of the innate immune system, such as activated CD11c ϩ NK cells may contribute to IFN-␥ production as well [4, 39] . Second, it is also shown that, in the absence of IFN-␥, C3H/HeJ DCs up-regulated CD86, but the primary cell cultures showed very little capacity to synthesize IFN-␥ upon secondary challenge with PAMPs and also down-regulation of T-bet gene.
These data speak to the possibility that during an ongoing microbial infection, cells of the innate immune system can attain variegated activation states due to direct or indirect stimulation, but the precise functional and pathophysiological consequences remain unclear. This idea has been tested in one system by demonstrating that indirect activation of DCs by CpG resulted in their diminished capacity to prime specific T cells [12] . Second, it has been shown that DCs up-regulate CD80/86 and MHC molecules in response to ␣-galactosylceramide-mediated NKT cell activation, but in the absence of CD40 signaling, they were unable to initiate a CD4 and CD8 T cell immune response [40] . In this report, we investigated a mechanism of attaining bystander DC activation. In addition to showing a role for IFN-␥, we also discovered enhanced responsiveness through the TLR9 pathway (Table 2 ). This was the case for both LPS (non) responsive cells.
LPS triggers a host innate immune response resulting in activation of various cell types and production of multiple cytokines. A number of hematopoetic and nonhematopoetic cells express abundant amounts of TLR4 [22] . Macrophages are the most prominent cells of the innate immune system, which express high levels of TLR4 and have been demonstrated to interact with LPS in vivo as compared with DCs or B cells [10] . DCs being terminally differentiated hematopoetic cells with a short half-life [41] , they express low TLR4 levels [5] [6] [7] [8] but possess highly specialized functions, such as very efficient processing and presentation of antigens. Also, DC exposure to LPS in vivo has been reported to mediate TLR4 gene down-regulation [7] and disappearance from T cell areas [42] . Even though the TLR4 levels are low, they may still be sufficient to activate DCs in a direct fashion. More in vivo work is needed to decipher the exact mechanism and contribution of the direct and bystander pathways.
In conclusion, our results demonstrated that enhanced responsiveness of bystander-activated cells to PAMPs was mediated through IFN-␥, and at least one cellular source of IFN-␥ producers were the recently described CD11c ϩ
CD49b
ϩ MHC class II ϩ NKDCs [30 -32] . These data suggest mechanisms of innate immune cell activation, including DCs in response to LPS and how the host may benefit from bystander activation. Alternatively, DC hyper-responsiveness to PAMPs may contribute to morbidity and mortality associated with septic shock.
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kϩ cells. Bone marrow was harvested from C57BL/6 (IFN-␥ ϩ/ϩ ), C57BL/6 (IFN-␥ Ϫ/Ϫ ), and C3H/HeJ mice and injected into irradiated recipient C3H/ HeJ mice. After 8 wk, chimeric mice were screened for percentage of bone marrow reconstitution. Recipient C3H/HeJ mice having reconstitution of ϳ1:1 were treated with PBS or upLPS. After 5 h, spleens were collagenase digested and C3H/HeJ cells enriched using CD11c MACS beads and then further purified using anti-IE k PE antibodies, followed by anti-PE. T-bet mRNA expression was assessed by real-time PCR and compared with HPRT. Data of 3 different experiments are given. (C57BL/6) and anti-IE k (C3H/HeJ) MACS column purification. Cells cultured without (none) or with 100 ng of CpG and poly I:C, and 24 h later, supernatants harvested and assayed for IFN-␥. Cells from PBS-injected mice were also stimulated with CpG and poly I:C in this assay but produced nondetectable levels of IFN-␥ (data not shown). These values are the data derived from 4 separate experiments.
